160 related articles for article (PubMed ID: 38288591)
1. Epigenetic Contributions to Clinical Risk Prediction of Cardiovascular Disease.
Chybowska AD; Gadd DA; Cheng Y; Bernabeu E; Campbell A; Walker RM; McIntosh AM; Wrobel N; Murphy L; Welsh P; Sattar N; Price JF; McCartney DL; Evans KL; Marioni RE
Circ Genom Precis Med; 2024 Feb; 17(1):e004265. PubMed ID: 38288591
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic scores for the circulating proteome as tools for disease prediction.
Gadd DA; Hillary RF; McCartney DL; Zaghlool SB; Stevenson AJ; Cheng Y; Fawns-Ritchie C; Nangle C; Campbell A; Flaig R; Harris SE; Walker RM; Shi L; Tucker-Drob EM; Gieger C; Peters A; Waldenberger M; Graumann J; McRae AF; Deary IJ; Porteous DJ; Hayward C; Visscher PM; Cox SR; Evans KL; McIntosh AM; Suhre K; Marioni RE
Elife; 2022 Jan; 11():. PubMed ID: 35023833
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Troponin T and Troponin I in the General Population.
Welsh P; Preiss D; Hayward C; Shah ASV; McAllister D; Briggs A; Boachie C; McConnachie A; Padmanabhan S; Welsh C; Woodward M; Campbell A; Porteous D; Mills NL; Sattar N
Circulation; 2019 Jun; 139(24):2754-2764. PubMed ID: 31014085
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic scores of blood-based proteins as biomarkers of general cognitive function and brain health.
Smith HM; Moodie JE; Monterrubio-Gómez K; Gadd DA; Hillary RF; Chybowska AD; McCartney DL; Campbell A; Redmond P; Page D; Taylor A; Corley J; Harris SE; Valdés Hernández M; Muñoz Maniega S; Bastin ME; Wardlaw JM; Deary IJ; Boardman JP; Mullin DS; Russ TC; Cox SR; Marioni RE
Clin Epigenetics; 2024 Mar; 16(1):46. PubMed ID: 38528588
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
Zhu K; Knuiman M; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Hung J
Heart; 2018 Jun; 104(11):895-903. PubMed ID: 29066610
[TBL] [Abstract][Full Text] [Related]
6. Integration of datasets for individual prediction of DNA methylation-based biomarkers.
Merzbacher C; Ryan B; Goldsborough T; Hillary RF; Campbell A; Murphy L; McIntosh AM; Liewald D; Harris SE; McRae AF; Cox SR; Cannings TI; Vallejos CA; McCartney DL; Marioni RE
Genome Biol; 2023 Dec; 24(1):278. PubMed ID: 38053194
[TBL] [Abstract][Full Text] [Related]
7. Ultrasensitive Troponin I and Incident Cardiovascular Disease.
Empana JP; Lerner I; Perier MC; Guibout C; Jabre P; Bailly K; Andrieu M; Climie R; van Sloten T; Vedie B; Geromin D; Marijon E; Thomas F; Danchin N; Boutouyrie P; Jouven X
Arterioscler Thromb Vasc Biol; 2022 Dec; 42(12):1471-1481. PubMed ID: 36325900
[TBL] [Abstract][Full Text] [Related]
8. A comparison of echocardiographic and circulating cardiac biomarkers for predicting incident cardiovascular disease.
Lind L; Loader J; Lindahl B; Eggers KM; Sundström J
PLoS One; 2022; 17(7):e0271835. PubMed ID: 35877671
[TBL] [Abstract][Full Text] [Related]
9. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT).
Jia X; Nambi V; Berry JD; Dalmacy D; Ascher SB; Taylor AA; Hoogeveen RC; de Lemos JA; Ballantyne CM
Clin Chem; 2024 Feb; 70(2):414-424. PubMed ID: 38084941
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic Assessment of Cardiovascular Disease Risk and Interactions With Traditional Risk Metrics.
Westerman K; Fernández-Sanlés A; Patil P; Sebastiani P; Jacques P; Starr JM; J Deary I; Liu Q; Liu S; Elosua R; DeMeo DL; Ordovás JM
J Am Heart Assoc; 2020 Apr; 9(8):e015299. PubMed ID: 32308120
[TBL] [Abstract][Full Text] [Related]
11. Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study.
Hughes MF; Ojeda F; Saarela O; Jørgensen T; Zeller T; Palosaari T; O'Doherty MG; Borglykke A; Kuulasmaa K; Blankenberg S; Kee F
Clin Chem; 2017 Jan; 63(1):334-342. PubMed ID: 28062627
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure.
Westerman K; Sebastiani P; Jacques P; Liu S; DeMeo D; Ordovás JM
Clin Epigenetics; 2019 Oct; 11(1):142. PubMed ID: 31615550
[TBL] [Abstract][Full Text] [Related]
13. Exercise-induced release of cardiac troponin is attenuated with repeated bouts of exercise: impact of cardiovascular disease and risk factors.
Somani YB; Uthman L; Aengevaeren VL; Rodwell L; Lip GYH; Hopman MTE; Van Royen N; Eijsvogels TMH; Thijssen DHJ
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H519-H524. PubMed ID: 36763505
[TBL] [Abstract][Full Text] [Related]
14. A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events.
Cappozzo A; McCrory C; Robinson O; Freni Sterrantino A; Sacerdote C; Krogh V; Panico S; Tumino R; Iacoviello L; Ricceri F; Sieri S; Chiodini P; McKay GJ; McKnight AJ; Kee F; Young IS; McGuinness B; Crimmins EM; Arpawong TE; Kenny RA; O'Halloran A; Polidoro S; Solinas G; Vineis P; Ieva F; Fiorito G
Clin Epigenetics; 2022 Sep; 14(1):121. PubMed ID: 36175966
[TBL] [Abstract][Full Text] [Related]
15. Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations.
Wu Z; Pilbrow AP; Liew OW; Chong JPC; Sluyter J; Lewis LK; Lasse M; Frampton CM; Jackson R; Poppe K; Camargo CA; Cameron VA; Scragg R; Richards AM
EBioMedicine; 2022 Aug; 82():104170. PubMed ID: 35850010
[TBL] [Abstract][Full Text] [Related]
16. Association of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.
Zheng Y; Joyce BT; Hwang SJ; Ma J; Liu L; Allen NB; Krefman AE; Wang J; Gao T; Nannini DR; Zhang H; Jacobs DR; Gross MD; Fornage M; Lewis CE; Schreiner PJ; Sidney S; Chen D; Greenland P; Levy D; Hou L; Lloyd-Jones DM
Circulation; 2022 Jul; 146(2):94-109. PubMed ID: 35652342
[TBL] [Abstract][Full Text] [Related]
17. Refining epigenetic prediction of chronological and biological age.
Bernabeu E; McCartney DL; Gadd DA; Hillary RF; Lu AT; Murphy L; Wrobel N; Campbell A; Harris SE; Liewald D; Hayward C; Sudlow C; Cox SR; Evans KL; Horvath S; McIntosh AM; Robinson MR; Vallejos CA; Marioni RE
Genome Med; 2023 Feb; 15(1):12. PubMed ID: 36855161
[TBL] [Abstract][Full Text] [Related]
18. Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study.
Lyngbakken MN; Røsjø H; Holmen OL; Dalen H; Hveem K; Omland T
Clin Chem; 2019 Jul; 65(7):871-881. PubMed ID: 30996050
[TBL] [Abstract][Full Text] [Related]
19. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
[TBL] [Abstract][Full Text] [Related]
20. Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.
de Lemos JA; Ayers CR; Levine BD; deFilippi CR; Wang TJ; Hundley WG; Berry JD; Seliger SL; McGuire DK; Ouyang P; Drazner MH; Budoff M; Greenland P; Ballantyne CM; Khera A
Circulation; 2017 May; 135(22):2119-2132. PubMed ID: 28360032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
